The country teams from the three project countries of the OH-EVI (Evidence-Informed Policy Approaches for One Health) project successfully held face-to-face workshops in Ghana, Croatia and Nigeria in January and February 2025. The workshops served two main purposes: validating each country’s One Health situation analysis and priority-setting, and…
The PharmTrain clinical fellowship involves fellows from the national medicines regulatory authorities (NMRAs) in Ghana, Zimbabwe, Tanzania and South Africa, i.e. from three different economic regions, thus covering large parts of Sub-Sahara Africa. This group committed to an intensive, multi-year journey to acquire both technical expertise and didactic skills within…
Ghana aims to establish official lot release for vaccines and biological products Five Regulatory Officers from the Food and Drugs Authority of Ghana (FDA Ghana) took part in a two-week training at the Paul-Ehrlich-Institut (PEI) in February 2024. The participating team covered a range of expert areas:…
Context Low-quality drugs pose a substantial threat to individual and public health. Issues include incorrect labelling, potentially toxic or wrong active ingredients and unacceptably high levels of impurities. Low-quality anti-infective medicines, in particular, pose a potentially global concern as they can lead to the development of antimicrobial resistance, making the…
Biosimilars and their importance for the African Continent Biotechnologically manufactured medicines are becoming more and more important, especially for the treatment of cancer, diabetes, and viral diseases. These products are often very expensive due to their complex development and manufacturing processes. However, after a certain period, these products may be…
The VaccRelease project supports African partner countries in establishing reliable official lot release to monitor the safety of vaccine lots. This includes: technical advice on analysing weaknesses using the WHO Global Benchmarking Tool, developing country-specific regulatory structures such as regulations, guidelines, and standard operating procedures, building competencies as needed. Training…
‘We need to collaborate! Let’s go far together.’ Under the leadership of the African Union, the African continent is working hard to expand its own vaccine production. At the same time, this requires strict state control and monitoring of locally produced vaccine lots. As for regulatory authorities and official control…
Context Antimicrobial resistance (AMR) is a global problem that jeopardises the successful treatment and control of infectious diseases. Each year, millions of people – particularly children under the age of five who are the most vulnerable to resistant pathogens – die of AMR-related infections. Effective surveillance systems are key to…
Context The project addresses the third United Nations Sustainable Development Goal (Good health and well-being), contributing to the fight against communicable diseases. In modern human medicine, the use of drugs is essential for the treatment of infectious diseases. However, many pathogens develop resistance to drugs through genetic adaptation, and this…